- Home
- BLUE vs CLSD Comparison
BLUE vs CLSD Comparison
Compare BLUE & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLUE
- CLSD
- Stock Information
- Founded
- BLUE 1992
- CLSD 2011
- Country
- BLUE United States
- CLSD United States
- Employees
- BLUE N/A
- CLSD N/A
- Industry
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- BLUE Health Care
- CLSD Health Care
- Exchange
- BLUE Nasdaq
- CLSD Nasdaq
- Market Cap
- BLUE 82.2M
- CLSD 70.5M
- IPO Year
- BLUE 2013
- CLSD 2016
- Fundamental
- Price
- BLUE $8.14
- CLSD $0.92
- Analyst Decision
- BLUE Hold
- CLSD Strong Buy
- Analyst Count
- BLUE 9
- CLSD 6
- Target Price
- BLUE $49.14
- CLSD $5.33
- AVG Volume (30 Days)
- BLUE 292.7K
- CLSD 301.0K
- Earning Date
- BLUE 11-14-2024
- CLSD 03-11-2025
- Dividend Yield
- BLUE N/A
- CLSD N/A
- EPS Growth
- BLUE N/A
- CLSD N/A
- EPS
- BLUE N/A
- CLSD N/A
- Revenue
- BLUE $53,120,000.00
- CLSD $7,703,000.00
- Revenue This Year
- BLUE $145.88
- CLSD N/A
- Revenue Next Year
- BLUE $239.89
- CLSD $91.87
- P/E Ratio
- BLUE N/A
- CLSD N/A
- Revenue Growth
- BLUE 144.50
- CLSD 248.39
- 52 Week Low
- BLUE $5.80
- CLSD $0.80
- 52 Week High
- BLUE $38.40
- CLSD $2.12
- Technical
- Relative Strength Index (RSI)
- BLUE 47.80
- CLSD 41.59
- Support Level
- BLUE $7.96
- CLSD $0.90
- Resistance Level
- BLUE $8.46
- CLSD $0.97
- Average True Range (ATR)
- BLUE 0.68
- CLSD 0.05
- MACD
- BLUE -0.06
- CLSD 0.00
- Stochastic Oscillator
- BLUE 15.42
- CLSD 17.73
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.